December 2022 - Ludlow Research

MetAlert (MLRT) Eliminates Toxic Debt, Launches New Medical Device Products

December 7, 2022January 9, 2023Ludlow Research

(NEW YORK) — Ludlow Research updated its research opinion on MetAlert, Inc. (OTC: MLRT), a pioneer in location sensitive health monitoring devices and wearable technology products for remote patient monitoring, based on elimination of toxic debt and launch of new medical device products for cognitive markets. Read recent Analyst Brief conducted Jan. 05, 2023 https://ludlowresearch.com/mlrt-analyst-brief-012023/ […]

Ehave (EHVVF) Bullish Outlook on Recession and Growing Mental Health Crisis

December 7, 2022June 25, 2023Ludlow Research

(NEW YORK)–Ludlow Research initiates research opinion on Ehave, Inc. (OTC: EHVVF), a leading healthcare services and technology company, based on growing risk for mental health crisis and demand for alternative treatment options. BULLISH OUTLOOK IN RECESSION Ehave is a healthcare technology company, which is focused on healthcare data collection, management, and analytics for the mental […]